The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Birth Defects After Early Pregnancy Use of Antithyroid Drugs: A Danish Nationwide Study
Abstract
INTRODUCTION: Hyperthyroidism in pregnant women should be adequately treated to prevent maternal and fetal complications, but teratogenic effects of antithyroid drug (ATD) treatment have been described. Evidence is still lacking in regard to the safety and choice of ATD in early pregnancy. OBJECTIVE: Our objective was to determine to which degree the use of methimazole (MMI)/carbimazole (CMZ) and propylthiouracil (PTU) in early pregnancy is associated with an increased prevalence of birth defects. METHODS: This Danish nationwide register-based cohort study included 817 093 children live-born from 1996 to 2008. Exposure groups were assigned according to maternal ATD use in early pregnancy: PTU (n = 564); MMI/CMZ (n = 1097); MMI/CMZ and PTU (shifted in early pregnancy [n = 159]); no ATD (ATD use, but not in pregnancy [n = 3543]); and nonexposed (never ATD use [n = 811 730]). Multivariate logistic regression was used to estimate adjusted odds ratio (OR) with 95% confidence interval (95% CI) for diagnosis of a birth defect before 2 years of age in exposed versus nonexposed children. RESULTS: The prevalence of birth defects was high in children exposed to ATD in early pregnancy (PTU, 8.0%; MMI/CMZ, 9.1%; MMI/CMZ and PTU, 10.1%; no ATD, 5.4%; nonexposed, 5.7%; P < .001). Both maternal use of MMI/CMZ (adjusted OR = 1.66 [95% CI 1.35-2.04]) and PTU (1.41 [1.03-1.92]) and maternal shift between MMI/CMZ and PTU in early pregnancy (1.82 [1.08-3.07]) were associated with an increased OR of birth defects. MMI/CMZ and PTU were associated with urinary system malformation, and PTU with malformations in the face and neck region. Choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, and aplasia cutis were common in MMI/CMZ-exposed children (combined, adjusted OR = 21.8 [13.4-35.4]). CONCLUSIONS: Both MMI/CMZ and PTU were associated with birth defects, but the spectrum of malformations differed. More studies are needed to corroborate results in regard to early pregnancy shift from MMI/CMZ to PTU. New ATD with fewer side effects should be developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Defects that may be observed in 2%-4% of exposed children (462,463) have included aplasia cutis; choanal atresia, esophageal, and other types of gut atresias; abdominal wall abnormalities including omphalocale; and eye, heart, and urinary tract malformations.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [463]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danish National Prescription Registry
Wallach‐Kildemoes, H., Sørensen, H. T., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,490
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Self-citationThe Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
The Danish Medical Birth Registry.
Lb, K., & Olsen, J. (1998) · PubMed · Cited by 803
Self-citationThe Danish prescription registries.
Gaist, D., Sørensen, H. T., & Hallas, J. (1997) · PubMed · Cited by 570
Fetal and Neonatal Hyperthyroidism
Zimmerman, D. (1999) · Thyroid · doi:10.1089/thy.1999.9.727 · Cited by 288
MATERNAL HYPERTHYROIDISM AND CONGENITAL MALFORMATION IN THE OFFSPRING
Momotani, N., Ito, K., Hamada, N., Ban, Y., NISHIKAWA, Y., & Mimura, T. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00119.x · Cited by 238
Yoshihara, A., Noh, J., Yamaguchi, T., Ohye, H., Sato, S., Sekiya, K., Kosuga, Y., Suzuki, M., Matsumoto, M., Kunii, Y., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2860 · Cited by 231
A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy
Wing, D. A., Millar, L. K., Koonings, P. P., Montoro, M. N., & Mestman, J. H. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70390-6 · Cited by 218
Momotani, N., Noh, J. Y., Ishikawa, N., & Ito, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4347 · Cited by 209
Mestman, J. H. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.03.005 · Cited by 201
Do Pregnant Women Report Use of Dispensed Medications?
Olesen, C., Søndergaard, C., Thrane, N., Nielsen, G. L., den Berg, L. D. J., & Olsen, J. (2001) · Epidemiology · doi:10.1097/00001648-200109000-00006 · Cited by 179
Self-citationMethimazole and Propylthiouracil Equally Cross the Perfused Human Term Placental Lobule
Mortimer, R. H., Cannell, G. R., Addison, R. S., Johnson, L. P., Roberts, M. S., & Bernus, I. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4210 · Cited by 175
Neonatal Thyroid Function after Propylthiouracil Therapy for Maternal Graves' Disease
Cheron, R. G., Kaplan, M. M., Larsen, P. R., Selenkow, H. A., & Crigler, J. F. (1981) · New England Journal of Medicine · doi:10.1056/nejm198102263040907 · Cited by 160
Treatment of Hyperthyroidism in Pregnancy and Birth Defects
Clementi, M., Gianantonio, E. D., Cassina, M., Leoncini, E., Botto, L. D., & Mastroiacovo, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0652 · Cited by 153
Barbero, P., Valdéz, R., Rodriguez, H. A., Tiscornia, C., Mansilla, E., Allons, A., Coll, S., & Liascovich, R. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32497 · Cited by 128
Thyrotoxicosis and heart failure that complicate pregnancy
Sheffield, J. S., & Cunningham, F. G. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00944-x · Cited by 127
Larsen, H., Nielsen, G. L., Bendsen, J., Flint, C., Olsen, J., & Sørensen, H. T. (2003) · Scandinavian Journal of Public Health · doi:10.1080/14034940210134194 · Cited by 126
Self-citationCarbimazole embryopathy: An emerging phenotype
Foulds, N. C., Walpole, I., Elmslie, F., & Mansour, S. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30418 · Cited by 108
Andersen, S. L., Olsen, J., Wu, C. S., & Laurberg, P. (2013) · European Thyroid Journal · doi:10.1159/000350513 · Cited by 98
Self-citationMomotani, N. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3633 · Cited by 96
Korelitz, J. J., McNally, D. L., Masters, M. N., Li, S. X., Xu, Y., & Rivkees, S. A. (2013) · Thyroid® · doi:10.1089/thy.2012.0488 · Cited by 91
Taylor, P. N., & Vaidya, B. (2012) · European Thyroid Journal · doi:10.1159/000342920 · Cited by 84
Rosenfeld, H., Ornoy, A., Shechtman, S., & Diav‐Citrin, O. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03495.x · Cited by 82
Chen, C., Xirasagar, S., Lin, C.-C., Wang, L., Kou, Y. R., & Lin, H.-C. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03019.x · Cited by 81
Severe malformations in infant born to hyperthyroid woman on methimazole
Johnsson, E., Larsson, G., & Ljunggren, M. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63942-6 · Cited by 76
Glinoer, D., & Cooper, D. S. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283565b49 · Cited by 59
Severe Embryopathy and Exposure to Methimazole in Early Pregnancy
Karlsson, F. A., Axelssön, O., & Melhus, H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8126 · Cited by 57
Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy
Bowman, P., Osborne, N. J., Sturley, R., & Vaidya, B. (2011) · QJM · doi:10.1093/qjmed/hcq248 · Cited by 50
Fetal hydrops, associated with maternal propylthiouracil exposure, reversed by intrauterine therapy
Yanai, N., & Shveiky, D. (2004) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.977 · Cited by 32
Mestman, J. H. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(04)00015-6 · Cited by 32
Alamdari, S., Azizi, F., Delshad, H., Sarvghadi, F., Amouzegar, A., & Mehran, L. (2013) · Journal of Thyroid Research · doi:10.1155/2013/878467 · Cited by 31
Bowman, P., & Vaidya, B. (2011) · Journal of Thyroid Research · doi:10.4061/2011/235130 · Cited by 28
Propylthiouracil Is Teratogenic in Murine Embryos
Benavides, V. C., Mallela, M. K., Booth, C. J., Wendler, C. C., & Rivkees, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035213 · Cited by 27
Severe Embryopathy and Exposure to Methimazole in Early Pregnancy
Karlsson, F. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.947-a · Cited by 25
Iridic and retinal coloboma associated with prenatal methimazole exposure
Aramaki, M., Hokuto, I., Matsumoto, T., Ishimoto, H., Inoue, M., Kimura, T., Oikawa, Y., Ikeda, K., Yoshimura, Y., Takahashi, T., et al. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30917 · Cited by 24
Pharmacologic treatment of hyperthyroidism during pregnancy
Cassina, M., Donà, M., Gianantonio, E. D., & Clementi, M. (2012) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23012 · Cited by 22
Komoike, Y., Matsuoka, M., & Kosaki, K. (2013) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.21057 · Cited by 21
Embryonic exposure to propylthiouracil disrupts left‐right patterning in Xenopus embryos
van Veenendaal, N. R., Ulmer, B. M., Boskovski, M. T., Fang, X., Khokha, M. K., Wendler, C. C., Blum, M., & Rivkees, S. A. (2012) · The FASEB Journal · doi:10.1096/fj.12-218073 · Cited by 19
Antithyroid drug therapy of Graves’ hyperthyroidism: realistic goals and focus on evidence
Laurberg, P., Andersen, S., & Karmisholt, J. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.91 · Cited by 17
Self-citationAplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero
Löllgen, R., Calza, A., Schwitzgebel, V., & Pfister, R. E. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.099 · Cited by 13
Antithyroid Drug Treatment in Pregnancy
Lazarus, J. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2123 · Cited by 10
Neonatal Thyroid Function after Propylthiouracil Therapy for Maternal Gravesʼ Disease
Cheron, R. G., Kaplan, M. M., Larsen, P. R., Selenkow, H. A., & Crigler, J. F. (1981) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198109000-00002 · Cited by 6
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905-917.
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“3% above the background rate) was also observed after PTU exposure in early pregnancy (463), but these defects tended to be less severe than with MMI and included preauricular sinuses and cysts and urinary tract abnormalities (466).”
BackgroundInfluentialSelf-citationAlexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Self-citation2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K. G., & Pearce, S. H. S. (2018) · European Thyroid Journal · doi:10.1159/000490384 · Cited by 1,025
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W. T., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 567
Metadata
- Authors
- Andersen, S. L., Olsen, J., Wu, C. S., & Laurberg, P.
- Affiliations
- Aalborg University Hospital (DK)
- Aarhus University (DK)
- Corresponding author
- Andersen, Stine Linding
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-11
- Volume
- 98
- Issue
- 11
- Pages
- 4373-4381
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2102423760
- Cited by
- 267
- References
- 44
- Citations by year
- 2026: 12 · 2025: 6 · 2024: 8 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 29 · 2019: 23 · 2018: 27 · 2017: 24 · 2016: 29 · 2015: 23 · 2014: 22 · 2013: 1
- FWCI
- 19.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- antithyroid drugs, congenital malformations, early pregnancy, hyperthyroidism in pregnancy, methimazole, carbimazole, propylthiouracil, teratogenicity, choanal atresia, esophageal atresia, omphalocele, drug safety
- MeSH terms
- Abnormalities, Drug-Induced, Adult, Carbimazole, Denmark, Female, Humans, Hyperthyroidism, Infant, Newborn, Male, Methimazole, Pregnancy, Pregnancy Complications, Pregnancy Trimester, First, Propylthiouracil, Antithyroid Agents, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review